Since taking office in 2016, President Tsai Ing-wen (蔡英文) has spearheaded and been a vocal proponent of the government’s New Southbound Policy. As Tsai told the Yushan Forum last year, the policy’s central tenet is that “Taiwan assists Asia and Asia assists Taiwan.”
While many have dismissed this sentiment as idealistic, given that most countries have yet to officially recognize Taiwan, a new development is occurring that could provide increased visibility to Taiwan and even earn it a well-deserved seat at the World Health Assembly.
The Food and Drug Administration granted emergency use authorization to Medigen Vaccine Biologics Corp’s COVID-19 vaccine on July 19. The government has made the vaccine’s development a priority. On Aug. 14, the Central Epidemic Command Center said that 600,000 doses of the domestically developed vaccine were to be administered between Monday and Sunday. [Editor’s note: President Tsai Ing-wen received a dose of the Medigen vaccine at National Taiwan University’s College of Medicine in Taipei on Monday.]
In a world still recovering from a deadly pandemic, vaccine diplomacy has become central to the foreign policy of several states. Vaccines are required on a global scale, but access is limited.
Taiwan has been generating goodwill in the health sector, such as by donating more than 51 million masks to frontline workers in other countries. When India was struck by a second wave of COVID-19, Indian media focused on hospital oxygen shortages, and Taiwan provided India with 150 oxygen concentrators and 500 oxygen cylinders.
Taiwan could use vaccine diplomacy to elevate its role as a provider of health assistance to other countries to a new level.
One of the New Southbound Policy’s critical components is the strengthening of Taiwan’s ties with South Asia, ASEAN members, Australia and New Zealand. The development of the Medigen vaccine has the potential to advance this policy, especially with ASEAN members. Most ASEAN states urgently need vaccines and are relying on agreements with states on other continents. For example, Cambodia, Indonesia and Laos have imported vaccines from China. Concerns about the “great efficiency” of the Sinopharm COVID-19 vaccine might soon require them to obtain other vaccine brands.
Taiwan can learn from India’s vaccine diplomacy and the international goodwill it has generated. Despite its shortcomings, India has emerged as a normative power during the COVID-19 pandemic through its Vaccine Maitri, or Vaccine Friendship, initiative. Moreover, India’s decision to provide low-income countries, unable to compete with wealthy nations in procuring life-saving vaccines for their citizens, with large-scale access to low-cost, high-quality vaccines constitutes a significant act beyond vaccine diplomacy.
It demonstrates that the ascension of a leading power does not have to be malevolent. This message is more critical than ever as Beijing seeks global pre-eminence by tearing down the existing power structure and establishing a Sinocentric world order.
The critical nature of vaccine diplomacy is emphasized even more when the Global North is busy hoarding vaccines and striking exclusive deals with manufacturers to acquire inventories many times their requirements at the expense of impoverishment in the Global South. India has been lauded at the WTO and by numerous state leaders for Vaccine Maitri.
India might have accrued “brownie points” in international affairs that can be redeemed later. Its policy was corroborated by countries rushing to assist India during its second wave. By learning from India’s experiences, Taiwan can formulate a similar strategy. A vaccine diplomacy approach could result in more than just brownie points — it could increase economic deals.
The pandemic has had an unprecedented effect on the world, and vaccines have become a luxury item. Inequality in vaccine access has emerged as a significant issue, and COVID-19 vaccines are not widely available in developing countries. Although a handful of wealthy countries account for only 16 percent of the world’s population, they control 60 percent of vaccine sales internationally.
Taiwan’s domestically developed vaccine can be used effectively to assist its diplomatic allies, and pave the way for multiple trade and economic agreements. The nub of the New Southbound Policy appears to fit this scenario perfectly. Combining the policy and vaccine diplomacy would create an ideal environment in which Taiwanese foreign relations with Asian states could flourish.
While the policy alone might not be capable of persuading countries to recognize Taiwan, the addition of vaccine diplomacy would help. Taiwan’s road to recognition is a long one, but this would undoubtedly propel the nation forward.
Manoj Kumar Panigrahi is an assistant professor at O.P. Jindal Global University’s Jindal School of International Affairs in India. Ahan Gadkari is a law student at O.P. Jindal Global University.
Local media reported earlier this month that the Chinese Nationalist Party (KMT) criticized President Tsai Ing-wen (蔡英文) for referring to China as a “neighboring country,” saying that this is no different from a “two-state” model and that it amounts to changing the cross-strait “status quo.” I find it quite impossible to understand why civilized Taiwan continues to tolerate the existence of such a deceitful group that believes its own lies. The relationship between Taiwan and China is the relationship between two countries, and neither has any jurisdiction over the other — this is the undeniable “status quo.” Those who believe in the
The National Immigration Agency on Monday confirmed that the majority of foreign residents in Taiwan would once again be excluded from the government’s stimulus voucher program. The NT$5,000 Quintuple Stimulus Voucher would be available to 140,000 foreign spouses of Taiwanese and 16,000 Alien Permanent Resident Certificate holders, but about 870,000 Alien Resident Certificate (ARC) holders would be excluded from the program, regardless of whether they pay taxes. The government has not offered any explanation, but some have speculated that the intention is to prevent migrant workers from receiving the vouchers. Many migrant workers are from Southeast Asian countries and work as
On Thursday, China applied to join the Comprehensive and Progressive Trans-Pacific Partnership (CPTPP) — a regional economic organization whose 11 member countries have a combined GDP of US$11 trillion. That is less than China’s 2019 GDP of US$14.34 trillion, so why is China so eager to join? China says there are two main reasons: To consolidate its foreign trade and foreign investment base, and to fast-track economic and trade relations between China and member countries of the CPTPP free-trade area. China’s bilateral trade with these countries grew from US$78 billion in 2003 to US$685.1 billion last year, mostly because of China’s 2005
US President Joe Biden and Chinese President Xi Jinping (習近平) talked on the telephone on Thursday last week, the first time the two leaders have done so since Biden assumed the presidency. While each side sought to put their own gloss on the content of the conversation, some common ground did emerge. Biden reportedly said that both sides have a joint responsibility to ensure that competition between the US and China does not spiral into conflict and that there is no reason that the two nations are destined to fall into this trap. The day after the phone call, the Financial Times reported